Proliferative retinopathy as a feature of Vogt Koyanagi Harada Disease: a report of two cases

BMC Ophthalmology

Table 1 Summary of all documented Vogt Koyanagi Harada patients who developed proliferative retinopathy

Patient	Demographics	Initial VKH signs	Initial treatment	Time to develop proliferative retinopathy	Signs of proliferative retinopathy	Treatment	Outcome
1	22 years old African female	AC cells, hyperemic discs and ERD in both eyes	Oral prednisolone 100 mg every other day	One year	NVDs in both eyes	N/A	N/A
2	46 years old Indian female	AC cells with ERD in both eyes	80 mg prednisolone daily	8 months	NVDs in the left eye	Oral steroids	Regressed NVDs
3	19 years old Saudi female	bilateral granulomatous panuveitis with bullous ERD in both eyes	75 mg/daily	One year	NVD in the left eye with preretinal hemorrhages	Oral steroids, Azathioprine, PPV + MP	Resolved fibrous tissue and ERM, controlled inflammation
4	33 years old Saudi female	N/A	N/A	6 months	NVDs, NVE with pre-retinal hemorrhages in the left eye	Oral steroids, mycophenolate mofitel, intravitreal Ranibizumab	Regressed NVDs and NVEs, resolved pre-retinal hemorrhages and controlled inflammation

AC Anterior Chamber, ERD Exudative retinal detachment, ERM Epiretinal membrane, MP Membrane peeling, PPV Pars plana vitrectomy, N/A Not available, NVD Neovascularization of the optic disc, NVE Neovascularization elsewhere, VKH Vogt Koyanagi Harada

ISSN: 1471-2415